Tag Archives: Debjit Chattopadhyay

What Made H.C. Wainwright Downgrade Galapagos’ Stock?

Galapagos (GLPG – Research Report) received a Hold rating and a $123.00 price target from H.C. Wainwright analyst Debjit Chattopadhyay today. The company’s shares closed last Friday at $137.16, close to its 52-week low of $112.00. According to TipRanks.com, Chattopadhyay

H.C. Wainwright Keeps a Buy Rating on Hookipa Pharma (HOOK)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on Hookipa Pharma (HOOK – Research Report), with a price target of $15.00. The company’s shares closed last Thursday at $10.73. According to TipRanks.com, Chattopadhyay is

Molecular Partners AG (MLLCF) Receives a Buy from H.C. Wainwright

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on Molecular Partners AG (MLLCF – Research Report), with a price target of CHF25.00. The company’s shares closed last Tuesday at $22.25. According to TipRanks.com, Chattopadhyay

H.C. Wainwright Keeps a Buy Rating on Amicus (FOLD)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on Amicus (FOLD – Research Report), with a price target of $20.00. The company’s shares closed last Monday at $15.23, close to its 52-week high of

Jounce Therapeutics (JNCE) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Jounce Therapeutics (JNCE – Research Report) today and set a price target of $8.00. The company’s shares closed last Friday at $4.80. According to TipRanks.com, Chattopadhyay is a 5-star analyst

H.C. Wainwright Reiterates a Buy Rating on MacroGenics (MGNX)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright reiterated a Buy rating on MacroGenics (MGNX – Research Report), with a price target of $40.00. The company’s shares closed last Thursday at $26.75. According to TipRanks.com, Chattopadhyay is a